VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies1The first two authors have contributed equally to the present work.1

This publication has 60 references indexed in Scilit:

• Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP
  Journal of Neuroimmunology, 1995
• Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages
  Peptides, 1994
• Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex
  Journal of Neuroimmunology, 1994
• Gene Expression of VIP Receptor in Rat Lymphocytes
  Biochemical and Biophysical Research Communications, 1994
• Type I receptors for PACAP (a neuropeptide even more important than VIP?)
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
• Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
  Journal of Neuroimmunology, 1993
• Structural requirements for the occupancy of pituitary adenylate‐cyclase‐activating‐peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranes
  European Journal of Biochemistry, 1992
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
  Biochemical and Biophysical Research Communications, 1989
• Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
  Biochemical and Biophysical Research Communications, 1989
• Retinal inhibits TPA activated, calcium-dependent, phospholipid-dependent protein kinase (“C” kinase)
  Biochemical and Biophysical Research Communications, 1983